Dashboard
Manage Tickers

AVTEAerovate Therapeutics, Inc.

Nasdaq aerovatetx.com


$ 1.95 $ 0.08 (4.28 %)    

Monday, 26-Aug-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.46 $ -4.66 (-0.97 %)
DIA $ 412.48 $ 0.89 (0.22 %)
SPY $ 560.78 $ -1.34 (-0.24 %)
TLT $ 98.13 $ -0.25 (-0.25 %)
GLD $ 232.75 $ 0.74 (0.32 %)
$ 1.95
$ 1.88
$ 1.94 x 400
$ 1.95 x 298
$ 1.88 - $ 1.95
$ 1.25 - $ 32.42
434,575
na
56.29M
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 03-25-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-29-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-30-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

aerovate-therapeutics-to-explore-strategic-alternatives-which-may-include-but-are-not-limited-to-an-acquisition-merger-reverse-merger-business-combination-liquidation-or-other-transaction
Aerovate Therapeutics To Explore Strategic...
07/08/2024 12:05:52

Aerovate Therapeutics, Inc. (NASDAQ:AVTE), which previously announced it was halting enrollment and shutting down the Phase 3 p...

watching-aerovate-therapeutics-shares-moving-higher-after-ra-cap-management-buys-928110-shares
Watching Aerovate Therapeutics; Shares Mov...
06/21/2024 13:41:39

evercore-isi-group-downgrades-aerovate-therapeutics-to-in-line-lowers-price-target-to-2
Evercore ISI Group Downgrades Aerovate The...
06/18/2024 17:55:22

Evercore ISI Group analyst Liisa Bayko downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Outperform to In-Line and lowers ...

guggenheim-downgrades-aerovate-therapeutics-to-neutral
Guggenheim Downgrades Aerovate Therapeutic...
06/18/2024 16:51:34

Guggenheim analyst Vamil Divan downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Buy to Neutral.

wells-fargo-downgrades-aerovate-therapeutics-to-equal-weight-lowers-price-target-to-2
Wells Fargo Downgrades Aerovate Therapeuti...
06/18/2024 14:28:26

Wells Fargo analyst Tiago Fauth downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Overweight to Equal-Weight and lowers th...

td-cowen-downgrades-aerovate-therapeutics-to-hold
TD Cowen Downgrades Aerovate Therapeutics ...
06/18/2024 09:42:07

TD Cowen analyst Joseph Thome downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Buy to Hold.

nasdaq-surges-over-200-points-aarons-shares-jump
Nasdaq Surges Over 200 Points; Aaron's Sha...
06/17/2024 18:40:51

jefferies-downgrades-aerovate-therapeutics-to-hold-lowers-price-target-to-2
Jefferies Downgrades Aerovate Therapeutics...
06/17/2024 18:23:24

Jefferies analyst Eun Yang downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Buy to Hold and lowers the price target from ...

why-ovid-therapeutics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Ovid Therapeutics Shares Are Trading L...
06/17/2024 17:21:47

btig-downgrades-aerovate-therapeutics-to-neutral
BTIG Downgrades Aerovate Therapeutics to N...
06/17/2024 17:07:31

BTIG analyst Julian Harrison downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Buy to Neutral.

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/17/2024 16:31:43

crude-oil-rises-1-mustang-bio-shares-spike-higher
Crude Oil Rises 1%; Mustang Bio Shares Spi...
06/17/2024 16:16:09

why-is-small-cap-heart-disease-focused-aerovate-therapeutics-stock-plummeting-on-monday
Why Is Small Cap-Heart Disease Focused Aer...
06/17/2024 13:52:05

Aerovate Therapeutics shares dropped 90.4% following the release of Phase 2b trial results for AV-101 for pulmonary arterial hy...

us-stocks-mixed-dow-tumbles-over-100-points
US Stocks Mixed; Dow Tumbles Over 100 Points
06/17/2024 13:40:41

aerovate-therapeutics-announces-24-week-topline-results-from-phase-2b-portion-of-impahct-evaluating-av-101-for-pulmonary-arterial-hypertension
Aerovate Therapeutics Announces 24-Week To...
06/17/2024 12:33:35

trading-halt-halted-at-82500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 8:25:00 a.m. ET - ...
06/17/2024 12:25:04

wedbush-reiterates-outperform-on-aerovate-therapeutics-maintains-41-price-target
Wedbush Reiterates Outperform on Aerovate ...
06/06/2024 13:53:21

Wedbush analyst Laura Chico reiterates Aerovate Therapeutics (NASDAQ:AVTE) with a Outperform and maintains $41 price target.

wedbush-reiterates-outperform-on-aerovate-therapeutics-maintains-41-price-target
Wedbush Reiterates Outperform on Aerovate ...
05/22/2024 14:58:46

Wedbush analyst Laura Chico reiterates Aerovate Therapeutics (NASDAQ:AVTE) with a Outperform and maintains $41 price target.

aerovate-therapeutics-presents-baseline-data-from-phase-2b-portion-of-impahct-trial-at-ats-2024-international-conference
Aerovate Therapeutics Presents Baseline Da...
05/21/2024 20:21:30

Baseline characteristics reflect a PAH population with significant disease Topline data from Phase 2b portion of IMPAHCT study ...

wedbush-reiterates-outperform-on-aerovate-therapeutics-maintains-41-price-target
Wedbush Reiterates Outperform on Aerovate ...
05/14/2024 12:34:43

Wedbush analyst Laura Chico reiterates Aerovate Therapeutics (NASDAQ:AVTE) with a Outperform and maintains $41 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION